Lopez-Boado, Y. S.; Rubin, B. K. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Current Opinion in Pharmacology. 2008, roč. 8, čís. 3, s. 286–291. doi:10.1016/j.coph.2008.01.010. PMID18339582. (anglicky)
Tenson, T.; Lovmar, M.; Ehrenberg, M. (2003). "The Mechanism of Action of Macrolides, Lincosamides and Streptogramin B Reveals the Nascent Peptide Exit Path in the Ribosome". Journal of Molecular Biology330 (5): 1005–1014. doi:10.1016/S0022-2836(03)00662-4. PMID12860123.
Keicho; N.; Kudoh, S.;. Diffuse panbronchiolitis: role of macrolides in therapy. American Journal of Respiratory Medicine. 2002, roč. 1, čís. 2, s. 119–131. PMID14720066. (anglicky)
Lopez-Boado, Y. S.; Rubin, B. K. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Current Opinion in Pharmacology. 2008, roč. 8, čís. 3, s. 286–291. doi:10.1016/j.coph.2008.01.010. PMID18339582. (anglicky)
Sanfilippo, A. (1976). "Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases". Journal of Pediatric Surgery11 (2): 177–180. PMID1263054.
Honein, M. A.; Paulozzi, L. J.; Himelright, I. M.; Lee, B.; Cragan, J. D.; Patterson, L.; Correa, A.; Hall, S. et al. (1999). "Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: A case review and cohort study". Lancet354 (9196): 2101–2105. doi:10.1016/S0140-6736(99)10073-4. PMID10609814